EFFECT OF SUPPLEMENTATION KAYU MANIS (CINNAMOMUM BURMANNII) EXTRACT IN NEURONAL CELL DEATH PROTECTION IN WISTAR RATS LIR-PSYCHOTIC ON HALOPERIDOL THERAPY

Authors

  • Radiyati Umi Partan Department of Internal Medicine, Faculty of Medicine, Sriwijaya University, Palembang, Indonesia.
  • Rachmat Hidayat Biomolecular Laboratory, Faculty of Medicine, Sriwijaya University, Palembang, Indonesia.
  • Mgs Irsan Saleh Department of Pharmacology, Faculty of Medicine Sriwijaya University, Palembang, Indonesia.
  • Nita Parisa Department of Pharmacology, Faculty of Medicine Sriwijaya University, Palembang, Indonesia.
  • Nia Savitri Tamzil Department of Pharmacology, Faculty of Medicine Sriwijaya University, Palembang, Indonesia.

DOI:

https://doi.org/10.22159/ajpcr.2018.v11i2.22024

Keywords:

Kayu manis (Cinnamomum burmannii), Apoptosis, Psychotic, Rat, Active caspase-3

Abstract

 Objective: The objective of this study was to determine the neuronal cell protective effect from kayu manis extract by inhibition activating active caspase-3 in Wistar rats lir psychotic-like behavior on haloperidol therapy.

Methods: An experimental in vivo study, an 8-week-old male Wistar rats (n=30) were used. Wistar rats were randomized into six groups. Group A: 5 rats as control without induced psychosis-like behavior and aquadest or drugs. Group B: 5 rats were induced psychosis-like behavior (ketamine 30 mg/kgBW, intraperitoneal for 5 days) and aquadest. Group C: 5 rats were induced psychosis-like behavior and haloperidol 0.5 mg/kgBW, per oral, 28 days. Group D: 5 rats were induced psychosis-like behavior, haloperidol 0.5 mg/kgBW, and kayu manis extract 50 mg/kgBW, per oral, 28 days. Group E: 5 rats were induced psychosis-like behavior, haloperidol 0.5 mg/kgBW, and kayu manis extract 100 mg/kgBW, per oral, 28 days. Group F: 5 rats were induced psychosis-like behavior, haloperidol 0.5 mg/kgBW, and kayu manis extract 200 mg/kgBW, per oral, 28 days. Negative symptoms of schizophrenia were assessed by social interactivity test pre and post. Apoptosis of neuronal cells in ventral tegmental area was assessed by immunohistochemistry of active caspase-3. The area stained was calculated as a percentage of total area within a field by program ImageJ.

Results: Active caspase-3 percentage area for group's treatment with only haloperidol was more wide than groups treatment with combination haloperidol and kayu manis extract.

Conclusion: Kayu manis extract can protect neuronal cell death through inhibition activating of active caspase-3 in Wistar rats psychotic-like behavior on haloperidol therapy.

Downloads

Download data is not yet available.

References

Lewis DA, Lieberman JA. Catching up on schizophrenia: Natural history and neurobiology. Neuron 2000;28:325-34.

Sathiya S, Babu CS. Telmisartan alleviates nitrosative stress in turn dopaminergic degeneration in mice mptp model of parkinsonism-biochemical and histopathological evidences. Int J Pharm Pharm Sci 2013;7:97-101.

Javitt DC. Glycine transport inhibitors and the treatment of schizophrenia. Biol Psychiatr 2008;63:6-8.

Frankle TF. PI3K/Akt: Getting it right matters. Oncogene 2008;27:6473-88.

Niizuma K, Endo H, Chan PH. Oxidative stress and mitochondrial dysfunction as determinants of ischemic neuronal death and survival. J Neurochem 2009;109 Suppl 1:133-8.

Ranasinghe P. Effects of Cinnamomum zeylanicum (Ceylon cinnamon) on blood glucose and lipids in a diabetic and healthy rat model. Pharmacogn Res 2012;4:73-9.

Fine AM. Oligomeric proanthocyanidin complexes: History, structure, and phytopharmaceuticalapplications. Altern Med Rev 2000;5:144-51.

Zayachkivska OS, Gzhegotsky MR, Terletska OI, Lutsyk DA, Yaschenko AM, Dzhura OR. Influence of Viburnum opulus proanthocyanidins on stress-induced gastrointestinalmucosal damage. J Physiol Pharmacol 2006;57:155-67.

Lindenboim L, Yuan J, Stein R. Bcl-xS and bax induce different apoptotic pathways in PC12 cells. Oncogene 2000;19:1783-93.

Braun T, Dar S, Vorobiov D, Lindenboim L, Dascal N, Stein R. Expression of Bcl-x(S) in Xenopus oocytes induces BH3-dependent and caspase-dependent cytochrome c release and apoptosis. Mol Cancer Res 2003;1:186-94.

Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, et al. Mediation of poly (ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 2002;297:259-63.

Martinou JC, Desagher S, Antonsson B. Cytochrome c release from mitochondria: All or nothing. Nat Cell Biol 2000;2:E41-3.

Vrablic AS, Albright CD, Craciunescu CN, Salganik RI, Zeisel SH. Altered mitochondrial function and overgeneration of reactive oxygen species precede the induction of apoptosis by 1-O-octadecyl-2-methyl-rac-glycero-3-phosphocholine in p53-defective hepatocytes. FASEB J 2001;15:1739-44.

Salganik RI, Albright CD, Rodgers J, Kim J, Zeisel SH, Sivashinskiy MS, et al. Dietary antioxidant depletion: Enhancement of tumor apoptosis and inhibition of brain tumor growth in transgenic mice. Carcinogenesis 2000;21:909-14.

Shobana S, Naidu KA. Antioxidant activity of selected Indian spices. Prostaglandins Leukot Essent Fatty Acids 2000;62:107-10.

Dhuley JN. Anti-oxidant effects of cinnamon (Cinnamomum verum) bark and greater cardamon (Amomum subulatum) seeds in rats fed high fat diet. Indian J Exp Biol 1999;37:238-42.

Kim SJ, Han D, Moon KD, Rhee JS. Measurement of superoxide dismutase-like activity of natural antioxidants. Biosci Biotechnol Biochem 1995;59:822-6.

Phukan P, Bawari M, Sengupta M. Promising neuroprotective plants from north-east India. Int J Pharm Pharm Sci 2015;7:28-39.

Lee HS, Kim BS, Kim MK. Suppression effect of Cinnamomum cassia bark-derived component on nitric oxide synthase. J Agric Food Chem 2002;50:7700-3.

Lin CC, Wu SJ, Chang CH, Ng LT. Antioxidant activity of Cinnamomum cassia. Phytother Res 2003;17:726-30.

Published

01-02-2018

How to Cite

Partan, R. U., R. Hidayat, M. I. Saleh, N. Parisa, and N. S. Tamzil. “EFFECT OF SUPPLEMENTATION KAYU MANIS (CINNAMOMUM BURMANNII) EXTRACT IN NEURONAL CELL DEATH PROTECTION IN WISTAR RATS LIR-PSYCHOTIC ON HALOPERIDOL THERAPY”. Asian Journal of Pharmaceutical and Clinical Research, vol. 11, no. 2, Feb. 2018, pp. 363-5, doi:10.22159/ajpcr.2018.v11i2.22024.

Issue

Section

Original Article(s)